English Français Español 中文 العربية

Eventos Noticias Análisis Organizadores

Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.

Acceso Ponentes Publicar su evento gratis

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

Industry Events
Noticias
Organizadores de eventos
Acerca de nosotros
Nuestros servicios
Organizador Premium
Event Pro
Conviértete en Ponente
Suscribirse

Términos
Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.

Eventos
Noticias
Análisis
Cuenta

English Français Español 中文 العربية

Eventos Noticias Análisis Organizadores

Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.

Acceso Ponentes Publicar su evento gratis

News

Categories

Últimas
Agricultura
Cadena de Suministro
China y BRICS+
Ciberseguridad
Defensa
Energía y Movilidad
Fintech
IA y Tecnología
Robótica
Salud
Semiconductores
Startups y Capital Riesgo

Select a category to explore the latest industry reporting.

NewsWednesday, 26 August 2026

Newsletter subscribe · Free

Buscar noticias

Últimas
IA y Tecnología
Ciberseguridad
Semiconductores
Robótica
Fintech
Energía y Movilidad
Defensa
Salud
Cadena de Suministro
Startups y Capital Riesgo
China y BRICS+
Agricultura

Noticias

Salud

Las últimas noticias, anuncios y análisis del sector Salud, provenientes de las conferencias, exposiciones y cumbres que dan forma al sector.

Últimas noticias de la sección

STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more

(opens original source in a new tab)

STAT News

STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not panning out

(opens original source in a new tab)

Ed Silverman·24 August 2026

FDA plans to regulate generative AI

(opens original source in a new tab)

STAT News

FDA plans to regulate generative AI

New clues to RFK Jr.'s vaccine plans, a bottleneck for nurse practitioners, and more health news from Morning Rounds

(opens original source in a new tab)

Theresa Gaffney·24 August 2026

STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns

(opens original source in a new tab)

STAT News

STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns

The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.

(opens original source in a new tab)

Jason Mast·24 August 2026

STAT+: Medicaid transgender care rule sets precedent that could restrict coverage of other drugs

(opens original source in a new tab)

STAT News

STAT+: Medicaid transgender care rule sets precedent that could restrict coverage of other drugs

The legal theory used to restrict gender-affirming care for minors could be applied broadly, experts say.

(opens original source in a new tab)

John Wilkerson·24 August 2026

STAT+: FDA digital health leader promises generative AI regulatory guidance is coming

(opens original source in a new tab)

STAT News

STAT+: FDA digital health leader promises generative AI regulatory guidance is coming

FDA expects to issue guidance on policies regarding generative AI devices, according to Rick Abramson, the agency’s head of digital health policy.

(opens original source in a new tab)

Mario Aguilar·24 August 2026

STAT+: Inside Moderna and Merck’s cancer vaccine triumph

(opens original source in a new tab)

STAT News

STAT+: Inside Moderna and Merck’s cancer vaccine triumph

Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges, and pandemic-era complications.

(opens original source in a new tab)

Matthew Herper, Jason Mast,and Angus Chen·24 August 2026

Opinion: Medicine stopped shaking hands. We should start again

(opens original source in a new tab)

STAT News

Opinion: Medicine stopped shaking hands. We should start again

A handshake takes only a few seconds but can make a major difference to a patient, an emergency physician writes.

(opens original source in a new tab)

Zain Khawaja·24 August 2026

Nurse practitioner trainees find themselves stymied by shortage of clinical mentors

(opens original source in a new tab)

STAT News

Nurse practitioner trainees find themselves stymied by shortage of clinical mentors

Nurse practitioner students face a preceptor shortage, often paying thousands to secure clinical supervision.

(opens original source in a new tab)

Colleen Connolly·24 August 2026

Americans bought 12% less soda under new SNAP restrictions, study says

(opens original source in a new tab)

STAT News

Americans bought 12% less soda under new SNAP restrictions, study says

The drop in soda purchases is meaningful, but not enormous, one of the study's authors said.

(opens original source in a new tab)

Sarah Todd·24 August 2026

STAT+: HHS document offers new clues to Kennedy’s vaccine plans

(opens original source in a new tab)

STAT News

STAT+: HHS document offers new clues to Kennedy’s vaccine plans

Kennedy asks for feedback on new vaccine recommendation categories, how shots are tested.

(opens original source in a new tab)

Chelsea Cirruzzo·21 August 2026

STAT+: Up and down the ladder: The latest comings and goings

(opens original source in a new tab)

STAT News

STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

(opens original source in a new tab)

Ed Silverman·21 August 2026

STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more

(opens original source in a new tab)

STAT News

STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more

Roche's Genentech will invest $750 million to double the size of its existing production facility in Oregon

(opens original source in a new tab)

Ed Silverman·21 August 2026

Los más leídos

STAT+: Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
FDA plans to regulate generative AI
STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
STAT+: Medicaid transgender care rule sets precedent that could restrict coverage of other drugs
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming

1
2
3
4
5
6
7

Industry Events
Noticias
Organizadores de eventos
Acerca de nosotros
Nuestros servicios
Organizador Premium
Event Pro
Conviértete en Ponente
Suscribirse

Términos
Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.

La semana en eventos de la industria, entregada cada viernes.

Un email corto. Las mejores historias de ferias, conferencias y cumbres que dan forma a los negocios mundiales. Sin relleno, sin spam, cancela en cualquier momento.

Sitio web

¿En qué sector trabaja? (opcional — nos ayuda a personalizar su resumen)